Recommendations for Pain Management in Cancer Patients
DOI:
https://doi.org/10.22270/ajprd.v12i2.1339Abstract
Pain is a symptom that is reported in cancer patients with the prevalence varying from 33% to 64%. Addressing pain remains a critical aspect of cancer treatment with research showing that pain management in this population remains inadequate. Addressing pain is instrumental because of the impact it has on a patient’s life. It affects clinical outcomes, contributes to poor quality of life, and leads to psychological distress. Barriers remain the key challenge that contributes to inadequate management. Addressing these barriers can lead to better outcomes. Carrying out a comprehensive patient assessment and screening is recommended before beginning pain management. Pain is multidimensional in nature and for many patients, different factors may be contributing to pain. Conducting a comprehensive assessment helps to identify these factors. Comprehensive assessment also helps to capture important information that can contribute to better pain management. After conducting an assessment, pain management should begin. Cancer pain can be managed using pharmacological and non-pharmacological interventions. The interventions should aim to improve patient comfort and function. The interventions should also provide more benefits than adverse effects. One of the mainstay interventions in managing cancer pain is opioids. Opioids should be given in accordance with recommendations from different guidelines to ensure they are effective.
Downloads
References
Van den Beuken-van Everdingen MH, De Rijke JM, Kessels AG, Schouten HC, Van Kleef M, Patijn J. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Annals of Oncology. 2007;18(9):1437-49.doi:10.1093/annonc/mdm056
Van Den Beuken-Van MH, Hochstenbach LM, Joosten EA, Tjan-Heijnen VC, Janssen DJ. Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. Journal of Pain and Symptom Management. 2016;51(6):1070-90.doi:10.1016/j.jpainsymman.2015.12.340
Money S, Garber B. Management of cancer pain. Current Emergency and Hospital Medicine Reports. 2018;6:141-6. doi:10.1007/s40138-018-0170-9
Fallon M, Giusti R, Aielli F, et al. Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines. Annals of Oncology. 2018;29:iv166-91.doi:10.1093/annonc/mds233
Ripamonti CI, Santini D, Maranzano E, Berti M, Roila F. Management of cancer pain: ESMO clinical practice guidelines. Annals of Oncology. 2012;23:vii139-54.doi:10.1093/annonc/mds233
Sun V, Borneman T, Piper B, Koczywas M, Ferrell B. Barriers to pain assessment and management in cancer survivorship. Journal of Cancer Survivorship. 2008;2:65-71. doi:10.1007/s11764-008-0047-0
Scarborough BM, Smith CB. Optimal pain management for patients with cancer in the modern era. CA: ACancer Journal for Clinicians. 2018;68(3):182-96.doi:10.3322/caac.21453
Ward SE, Goldberg N, Miller-McCauley V, et al. Patient-related barriers to management of cancer pain. Pain. 1993;52(3):319-24.doi:10.1016/0304-3959(93)90165-L
Jacobsen R, Møldrup C, Christrup L, Sjøgren P. Patient‐related barriers to cancer pain management: a systematic exploratory review. Scandinavian Journal of Caring Sciences. 2009;23(1):190-208.doi:10.1111/j.1471-6712.2008.00601.x
Gunnarsdottir S, Donovan HS, Serlin RC, Voge C, Ward S. Patient-related barriers to pain management: the Barriers Questionnaire II (BQ-II). Pain. 2002;99(3):385-96.doi:10.1016/S0304-3959(02)00243-9
Potter VT, Wiseman CE, Dunn SM, Boyle FM. Patient barriers to optimal cancer pain control. Psycho‐Oncology: Journal of the Psychological, Social and Behavioral Dimensions of Cancer. 2003;12(2):153-60.
Al-Ghabeesh SH, Bashayreh IH, Saifan AR, Rayan A, Alshraifeen AA. Barriers to effective pain management in cancer patients from the perspective of patients and family caregivers: A qualitative study. Pain Management Nursing. 2020 Jun 1;21(3):238-44.doi:10.1016/j.pmn.2019.07.011
Orujlu S, Hassankhani H, Rahmani A, Sanaat Z, Dadashzadeh A, Allahbakhshian A. Barriers to cancer pain management from the perspective of patients: A qualitative study. Nursing Open. 2022;9(1):541-9.doi:10.1002/nop2.1093
Peacock S, Patel S. Cultural influences on pain. Reviews in Pain. 2008;1(2):6-9.
Givler A, Bhatt H, Maani-Fogelman PA. The importance of cultural competence in pain and palliative care.2024.https://www.ncbi.nlm.nih.gov/books/NBK493154/
Paice JA, Ferrell B. The management of cancer pain. CA: A Cancer Journal for Clinicians. 2011;61(3):157-82. doi:10.3322/caac.20112
Graetz I, Yarbrough CR, Hu X, Howard DH. Association of mandatory-access prescription drug monitoring programs with opioid prescriptions among Medicare patients treated by a medical or hematologic oncologist. JAMA Oncology. 2020;6(7):1102-3.doi:10.1001/jamaoncol.2020.0804
Oldenmenger WH, Smitt PA, van Dooren S, Stoter G, van der Rijt CC. A systematic review on barriers hindering adequate cancer pain management and interventions to reduce them: a critical appraisal. European Journal of Cancer. 2009;45(8):1370-80.doi:10.1016/j.ejca.2009.01.007
Shute C. The challenges of cancer pain assessment and management. The Ulster Medical Journal. 2013;82(1):40.
Toba HA, Samara AM, Zyoud SE. Nurses’ knowledge, perceived barriers, and practices regarding cancer pain management: a cross-sectional study from Palestine. BMC Medical Education.2019;19:1-7.doi:10.1186/s12909-019-1613-z
Kwon JH. Overcoming barriers in cancer pain management. Journal of Clinical Oncology. 2014;32(16):1727-33.doi:10.1200/JCO.2013.52.4827
Silvoniemi M, Vasankari T, Vahlberg T, Vuorinen E, Clemens KE, Salminen E. Physicians’ self-assessment of cancer pain treatment skills-more training required. Supportive Care in Cancer.2012;20:2747-53.doi:10.1007/s00520-012-1396-9
Breuer B, Fleishman SB, Cruciani RA, Portenoy RK. Medical oncologists’ attitudes and practice in cancer pain management: a national survey. J Clin Oncol. 2011;29(36):4769-75.doi:10.1200/JCO.2011.35.0561
Anderson KO, Richman SP, Hurley J, et al. Cancer pain management among underserved minority outpatients: perceived needs and barriers to optimal control. Cancer. 2002;94(8):2295-304. doi:10.1002/cncr.10414
Stephenson N, Dalton JA, Carlson J, Youngblood R, Bailey D. Racial and ethnic disparities in cancer pain management. Journal of National Black Nurses' Association: JNBNA. 2009;20(1):11-8.
Anderson KO, Green CR, Payne R. Racial and ethnic disparities in pain: causes and consequences of unequal care. The Journal of Pain. 2009;10(12):1187-204.doi:10.1016/j.jpain.2009.10.002
Dickason RM, Chauhan V, Mor A, et al. Racial differences in opiate administration for pain relief at an academic emergency department. Western Journal of Emergency Medicine. 2015;16(3):372.doi:10.5811/westjem.2015.3.23893
Caraceni A, Shkodra M. Cancer pain assessment and classification. Cancers. 2019;11(4):510.doi:10.3390/cancers11040510
National Cancer Institute. Cancer Pain (PDQ®)–Patient Version. 2024. Accessed April 7 2024.https://www.cancer.gov/about-cancer/treatment/side-effects/pain/pain-pdq
Turk DC, Okifuji A. Psychological factors in chronic pain: evolution and revolution. Journal of consulting and clinical psychology. 2002 Jun;70(3):678.doi:10.1037//0022-006x.70.3.678
Paice JA, Portenoy R, Lacchetti C, et al. Management of chronic pain in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. Journal of Clinical Oncology. 2016;34(27):3325-45. doi:10.1200/JCO.2016.68.5206
Swarm RA, Paice JA, Anghelescu DL, et al. Adult cancer pain, version 3.2019, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network. 2019;17(8):977-1007.doi:10.6004/jnccn.2019.0038
Bhatia S, Pappo AS, Acquazzino M, et al. Adolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2023;21(8):851-80.doi:10.6004/jnccn.2023.0040.
Caraceni A, Cherny N, Fainsinger R, Kaasa S, Poulain P, Radbruch L, De Conno F. Pain measurement tools and methods in clinical research in palliative care: recommendations of an Expert Working Group of the European Association of Palliative Care. Journal of Pain and Symptom Management. 2002;23(3):239-55.doi:10.1016/s0885-3924(01)00409-2.
Fallon M, Walker J, Colvin L, Rodriguez A, Murray G, Sharpe M. Pain management in cancer center inpatients: a cluster randomized trial to evaluate a systematic integrated approach—the Edinburgh Pain Assessment and Management Tool. Journal of Clinical Oncology. 2018;36(13):1284.doi:10.1200/JCO.2017.76.1825
Hui D, Bruera E. A personalized approach to assessing and managing pain in patients with cancer. Journal of Clinical Oncology. 2014;32(16):1640.doi:10.1200/JCO.2013.52.2508
National Cancer Institute. Cancer Pain (PDQ®)–Health Professional Version. 2024. Accessed April 7 2024. https://www.cancer.gov/about-cancer/treatment/side-effects/pain/pain-hp-pdq
Mestdagh F, Steyaert A, Lavand’homme P. Cancer pain management: a narrative review of current concepts, strategies, and techniques. Current Oncology. 2023;30(7):6838-58.doi:10.3390/curroncol30070500
Kettyle G. Multidisciplinary approach to cancer pain management. The Ulster Medical Journal. 2023;92(1):55.
Derry S, Wiffen PJ, Moore RA, et al. Oral nonsteroidal anti‐inflammatory drugs (NSAIDs) for cancer pain in adults. Cochrane Database of Systematic Reviews. 2017(7).doi:10.1002/14651858.CD012638.pub2.
Nabal M, Librada S, Redondo MJ, Pigni A, Brunelli C, Caraceni A. The role of paracetamol and nonsteroidal anti-inflammatory drugs in addition to WHO Step III opioids in the control of pain in advanced cancer. A systematic review of the literature. Palliative Medicine. 2012;26(4):305-12. doi:10.1177/0269216311428528.
Jongen JL, Huijsman ML, Jessurun J, et al. The evidence for pharmacologic treatment of neuropathic cancer pain: beneficial and adverse effects. Journal of Pain and Symptom Management. 2013;46(4):581-90.doi:10.1016/j.jpainsymman.2012.10.230
Bennett MI. Effectiveness of antiepileptic or antidepressant drugs when added to opioids for cancer pain: systematic review. Palliative Medicine. 2011; 25(5):553-9.doi:10.1177/0269216310378546.
Wiffen PJ, Derry S, Moore RA. Tramadol with or without paracetamol (acetaminophen) for cancer pain. Cochrane Database of Systematic Reviews. 2017(5).doi:10.1002/14651858.CD012508.pub2
Beakley BD, Kaye AM, Kaye AD. Tramadol, pharmacology, side effects, and serotonin syndrome: a review. Pain Physician. 2015; 18(4):395.
Mercadante S, Porzio G, Ferrera P, et al. Low morphine doses in opioid-naive cancer patients with pain. Journal of Pain and Symptom Management. 2006;31(3):242-7.doi:10.1016/j.jpainsymman.2006.01.001
Dowell D. CDC clinical practice guideline for prescribing opioids for pain-United States, 2022. MMWR. Recommendations and reports. 2022;71.doi:10.15585/mmwr.rr7103a1.
Paley CA, Johnson MI, Tashani OA, Bagnall AM. Acupuncture for cancer pain in adults. Cochrane Database of Systematic Reviews. 2015(10).doi:10.1002/14651858.CD007753.pub3.
Chen ZJ, Guo YP, Wu ZC. Observation on the therapeutic effect of acupuncture at pain points on cancer pain. Zhongguo Zhen Jiu= Chinese Acupuncture & Moxibustion. 2008; 28(4):251-3.
Garcia MK, Driver L, Haddad R, et al. Acupuncture for treatment of uncontrolled pain in cancer patients: a pragmatic pilot study. Integrative Cancer Therapies. 2014; 13(2):133-40.doi:10.1177/1534735413510558.
Deng G. Integrative medicine therapies for pain management in cancer patients. The Cancer Journal. 2019; 25(5):343-8.doi:10.1097/PPO.0000000000000399
Pan CX, Morrison RS, Ness J, Fugh-Berman A, Leipzig RM. Complementary and alternative medicine in the management of pain, dyspnea, and nausea and vomiting near the end of life: a systematic review. Journal of Pain and Symptom Management. 2000; 20(5):374-87.doi:10.1016/s0885-3924(00)00190-1
Mishra SI, Scherer RW, Geigle PM, Berlanstein DR, Topaloglu O, Gotay CC, Snyder C. Exercise interventions on health‐related quality of life for cancer survivors. Cochrane Database of Systematic Reviews. 2012(8).doi:10.1002/14651858.CD007566.pub2.
Published
Versions
- 2024-04-15 (2)
- 2024-04-15 (1)
How to Cite
Issue
Section
Copyright (c) 2024 Pallav Dave
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.